25. Progressive multifocal leukoencephalopathy Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 26 /  Drugs : 35 - (DrugBank : 22) / Drug target genes : 8 - Drug target pathways : 37

Progressive multifocal leukoencephalopathy and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
IDDiseases (Sorted by drug repositionability)
25Progressive multifocal leukoencephalopathy
13Multiple sclerosis/Neuromyelitis optica
46Malignant rheumatoid arthritis
26HTLV-1-associated myelopathy
49Systemic lupus erythematosus
96Crohn disease
97Ulcerative colitis
28Systemic amyloidosis
40Takayasu arteritis
285Fanconi anemia
41Giant cell arteritis
56Behcet disease
11Myasthenia gravis
53Sjogren syndrome
34Neurofibromatosis
85Idiopathic interstitial pneumonia
51Scleroderma
16Crow-Fukase syndrome
220Rapidly progressive glomerulonephritis
30Distal myopathy